emopamil

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameemopamil
Drug Alias Namelevemopamil
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersSerotonin 2 (5-HT2) receptor antagonists
TargetsSerotonin 2 (5-HT2) receptorVoltage-gated calcium channel
Therapy Area/IndicationsNerve DegenerationMigraine DisordersStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKnoll Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKnoll Gmbh
Active IndicationsN/A
Inactive IndicationsNerve DegenerationMigraine DisordersStroke

Other Information

ATC CodeN/A
Related LinksN/A